"Macquarie Heart is a leading cardiovascular group with an integrated network of cardiologists, vascular and endovascular surgeons and general physicians. Our Specialists include Dr Edward Barin, Dr Peter Caspari, Dr William Chik, Dr Ruba Haddad, Dr Alex Jacobsen, Dr Elizabeth Shaw, Dr Michael Stephen, Dr Richard Kerdic, Dr Daniel Nguyen, Dr Martin Cullen and Dr Sanaz Tehrani. We can accommodate urgent appointments for consultations and diagnostic testing."

During the past decade, Macquarie Heart conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Macquarie Heart" are "Advanced Cancer" (1 trials) and "Urothelial Cancer" (1 trials). Many other conditions were trialed in "Macquarie Heart" in a lesser frequency.

Most popular intervention types in "Macquarie Heart" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (2 trials), "Best Supportive Care" (1 trials), "CMP-001" (1 trials), "Following the planned interim analysis for this study: Avelumab" (1 trials) and "PD 0360324" (1 trials). Other intervention names were less common.

The vast majority of trials in "Macquarie Heart" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Macquarie Heart". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Macquarie Heart, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Macquarie Heart, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".